From: Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations
Cases
Controls
(N=2,105)
(N=11,500)
Gender
Male
1,327 (63.0 %)
7,167 (62.3 %)
Age group
40-59
667 (31.7 %)
3,766 (32.8%)
60-69
627 (29.8 %)
3,392 (29.5%)
70-79
811 (38.5 %)
4,342 (37.8 %)